V. Apostolopoulos, J. Bojarska, T.T. Chai, S. Elnagdy, K. Kaczmarek, J. Matsoukas. A global review on short peptides: frontiers and perspectives. Molecules (Basel, Switzerland) 2021; 26(2): 430.

L. Wang, N. Wang, W. Zhang, X. Cheng, Z. Yan, G. Shao. Therapeutic peptides: current applications and future directions. Signal Transduction and Targeted Therapy 2022; 7(1): 48.

D. Bhandari, S. Rafiq, Y. Gat, P. Gat, R. Waghmare, V. Kumar. A review on bioactive peptides: physiological functions, bioavailability and safety. International Journal of Peptide Research and Therapeutics 2020; 26(1): 139-50.

K.G. Varnava, V. Sarojini. Making solid-phase peptide synthesis greener: a review of the literature. Chemistry, an Asian Journal 2019; 14(8): 1088-97.

D.F. Winkler. Automated solid-phase peptide synthesis. InPeptide Synthesis: Methods and Protocols 2019 Dec 27 (pp. 59-94). New York, NY: Springer US. InPeptide Synthesis: Methods and Protocols 2020; 2019: 59-94.

S. Basith, B. Manavalan, T. Hwan Shin, G. Lee. Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening. Medicinal Research Reviews 2020; 40(4): 1276-314.

L.T. Ngoc, J.Y. Moon, Y.C. Lee. Insights into bioactive peptides in cosmetics. Cosmetics 2023; 10(4): 111.

C.B. Falcao, G. Radis-Baptista. Crotamine and crotalicidin, membrane active peptides from Crotalus durissus terrificus rattlesnake venom, and their structurally-minimized fragments for applications in medicine and biotechnology. Peptides 2020; 126: 170234.

Z. Zhao, A. Ukidve, J. Kim, S. Mitragotri. Targeting strategies for tissue-specific drug delivery. Cell 2020; 181(1): 151-67.

S.Y. Tang, H. Wei, C.Y. Yu. Peptide-functionalized delivery vehicles for enhanced cancer therapy. International Journal of Pharmaceutics 2021; 593: 120141.

R.A. Bottens, T. Yamada. Cell-penetrating peptides (CPPs) as therapeutic and diagnostic agents for cancer. Cancers (Basel) 2022; 14(22): 5546.

M. Alas, A. Saghaeidehkordi, K. Kaur. Peptide-drug conjugates with different linkers for cancer therapy. Journal of Medicinal Chemistry 2021; 64(1): 216-32.

R. He, B. Finan, J.P. Mayer, R.D. DiMarchi. Peptide conjugates with small molecules designed to enhance efficacy and safety. Molecules (Basel, Switzerland) 2019; 24(10): 1855.

S.M. Vadevoo, S. Gurung, H.S. Lee, G.R. Gunassekaran, S.M. Lee, J.W. Yoon. Peptides as multifunctional players in cancer therapy. Experimental amp; Molecular Medicine 2023; 55(6): 1099-109.

A. Ayo, P. Laakkonen. Peptide-based strategies for targeted tumor treatment and imaging. Pharmaceutics 2021; 13(4): 481.

A.L. Tornesello, A. Borrelli, L. Buonaguro, F.M. Buonaguro, M.L. Tornesello. Antimicrobial peptides as anticancer agents: functional properties and biological activities. Molecules (Basel, Switzerland) 2020; 25(12): 2850.

S.F. Askari Rizvi, H. Zhang. Emerging trends of receptor-mediated tumor targeting peptides: A review with perspective from molecular imaging modalities. European Journal of Medicinal Chemistry 2021; 221: 113538.

P. Scodeller, E.K. Asciutto. Targeting tumors using peptides. Molecules (Basel, Switzerland) 2020; 25(4): 808.

D.J. Worm, S. Els-Heindl, A.G. Beck-Sickinger. Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates. Peptide Science 2020; 112(3): e24171.

T. Tashima. Delivery of Drugs into Cancer Cells Using Antibody-Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect. Antibodies (Basel) 2022; 11(4): 78.

B. Jafari, M.M. Pourseif, J. Barar, M.A. Rafi, Y. Omidi. Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors. Expert Opinion on Drug Delivery 2019; 16(6): 583-605.

A.A. Akatay, T. Wu, U. Djakbarova, C. Thompson, E. Cocucci, R. Zandi. Endocytosis at extremes: formation and internalization of giant clathrin-coated pits under elevated membrane tension. Frontiers in Molecular Biosciences 2022; 9: 959737.

F. Mejia, S. Khan, D.T. Omstead, C. Minetos, B. Bilgicer. Identification and optimization of tunable endosomal escape parameters for enhanced efficacy in peptide-targeted prodrug-loaded nanoparticles. Nanoscale 2022; 14(4): 1226-40.

M. Dudãu, E. Codrici, C. Tanase, M. Gherghiceanu, A.M. Enciu, M.E. Hinescu. Caveolae as potential hijackable gates in cell communication. Frontiers in Cell and Developmental Biology 2020; 8: 581732.

S. Kudruk, S. Pottanam Chali, A.L. Linard Matos, C. Bourque, C. Dunker, C. Gatsogiannis. Biodegradable and Dual-Responsive Polypeptide-Shelled Cyclodextrin-Containers for Intracellular Delivery of Membrane-Impermeable Cargo. Advanced Science 2021; 8(18): e2100694.

Y. Zhao, H. Jiang, J. Yu, L. Wang, J. Du. Engineered histidine-rich peptides enhance endosomal escape for antibody-targeted intracellular delivery of functional proteins. Angewandte Chemie International Edition in English 2023; 62(38): e202304692.

Y. Ju, H. Guo, M. Edman, S.F. Hamm-Alvarez. Application of advances in endocytosis and membrane trafficking to drug delivery. Advanced Drug Delivery Reviews 2020; 157: 118-41.

H. Cho, K.M. Huh, M.S. Shim, Y.Y. Cho, J.Y. Lee, H.S. Lee. Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: current strategies and beyond. Advanced Drug Delivery Reviews 2024; 212: 115386.

S. Fu, X. Xu, Y. Ma, S. Zhang, S. Zhang. RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy. Journal of Drug Targeting 2019; 27(1): 1-11.

R.K. Dhritlahre, A. Saneja. Recent advances in HER2-targeted delivery for cancer therapy. Drug Discovery Today 2021; 26(5): 1319-29.

E.D. Santos, K.A. Nogueira, L.C. Fernandes, J.R. Martins, A.V. Reis, J.B. Neto. EGFR targeting for cancer therapy: pharmacology and immunoconjugates with drugs and nanoparticles. International Journal of Pharmaceutics 2021; 592: 120082.